[1] 张辉,张小江,徐英春,等. 2012年中国CHINET不动杆菌属细菌耐药性监测[J]. 中国感染与化疗杂志,2014,14(5):392
[2] 习慧明,徐英春,朱德妹,等. 2010年中国CHINET鲍曼不动杆菌耐药性监测[J]. 中国感染与化疗杂志,2012,12(2):98
[3] 王玲巧,毛翠,张学锋,等. 鲍曼不动杆菌对氨基糖苷类药物的耐药机制研究[J]. 检验医学与临床,2010,7(7):584
[4] Kempf M,Rolain J. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options[J]. Int J Antimicrob Agents,2012, 39(2):105
[5] 张驰,杨羚,凌保东. 鲍曼不动杆菌8种RND外排泵介导替加环素耐药表型的研究[J]. 中国抗生素杂志,2018,43(2):115
[6] Lin M,Lin Y,Tu C,et al. Distribution of different efflux pump genes in clinical isolates of multidrug-resistant Acinetobacter baumannii and their correlation with antimicrobial resistance[J]. J Microbiol Immunol Infect,2017,50(2):224
[7] Rodríguez C H,Nastro M,Famiglietti A. Carbapenemases in Acinetobacter baumannii review of their dissemination in Latin America[J]. Rev Argent Microbiol,2018, 50(3):327
[8] 刘彦伶,毛静,贾蓓. 鲍曼不动杆菌耐药及治疗进展[J]. 国外医药(抗生素分册),2015, 36(2):63
[9] 罗鹏,戴玮,张莉萍. 1582株鲍曼不动杆菌的临床分布及耐药性分析[J]. 重庆医学,2011, 40(3):224
[10] 孙红爽,乜春城,陈赫军. 2012~2013年某院鲍曼不动杆菌的临床分布及耐药性分析[J]. 安徽医药,2015,19(1):189
[11] 徐桂婷,糜琛蓉,李文慧,等. 2008年~2012年住院患者鲍曼不动杆菌分布状况及耐药性分析[J]. 华西医学,2014,29(3):413
[12] 徐一鸣,王蓓,蒋晓飞. 2008至2012年鲍曼不动杆菌临床感染分布及耐药特征分析[J]. 检验医学,2014, 29(3):245
[13] Kang J,Gopala L,Reddy Tangadanchu V K,et al. Novel naphthalimide nitroimidazoles as multitargeting antibacterial agents against resistantAcinetobacter baumannii[J]. Future Med Chem,2018,10(7):711
[14] Soltani B,Heidari H,Ebrahim-Saraie H S,et al. Molecular characteristics of multiple and extensive drug-resistant Acinetobacter baumannii isolates obtained from hospitalized patients in Southwestern Iran[J]. Infez Med,2018,26(1):67
[15] Shukla M,Soni I,Matsuyama K,et al. Identification and bio-evaluation of SRI-12742 as a antimicrobial agent against multi-drug resistant Acinetobacter baumannii[J]. Int J Antimicrob Agents, 2018, 52(1):22
[16] 马玲,袁喆. 2006~2009年鲍曼不动杆菌感染分布特征及耐药性变迁[J]. 重庆医科大学学报,2010,35(8):1278
[17] 肖淑珍,徐桂婷,方洁,等. 鲍曼不动杆菌耐药性与抗菌药物使用情况的相关性分析[J]. 中国感染与化疗杂志,2013,13(6):446
[18] Fiester S E,Arivett B A,Beckett A C,et al. Miltefosine reduces the cytolytic activity and virulence of Acinetobacter baumannii[J]. Antimicrob Agents Chemother,2018, 63(1):e01409
[19] Wang T H,Leu Y S,Wang N Y,et al. Prevalence of different carbapenemase genes among carbapenem-resistant Acinetobacter baumannii blood isolates in Taiwan[J]. Antimicrob Resist Infect Control,2018,7:123
[20] Rui Y,Lu W,Li S,et al. Detection of common mobile genetic elements and genotyping of multidrug-resistant Gram-negative bacilli in blood specimens from septicemia patients in southern China[J]. Infect Drug Resist,2018,11:1741
[21] Kazmierczak K M,Tsuji M,Wise M G,et al. In vitro activity of cefiderocol,a siderophore cephalosporin,against a recent collection of clinically relevant carbapenem-nonsusceptible gram-negative bacilli,including serine carbapenemase- and metallo-beta-lactamase-producing isolates (SIDERO-WT-2014 Study)[J]. Int J Antimicrob Agents,2019, 53(2):177
[22] 潘慧. 鲍曼不动杆菌临床分布特征及耐药性分析[D]. 吉林大学,2015
[23] 王风娟,吕媛,李耘. 替加环素联合5种抗菌药物对多重耐药鲍曼不动杆菌的体外活性[J]. 中国临床药理学杂志,2013,29(5):345
[24] 晏奎,温汉春,陈一强,等. 磷霉素联合左氧氟沙星对鲍曼不动杆菌生物膜的体外研究[J]. 中国临床药理学杂志,2015, 31(4):276
[25] 张雪云,褚云卓,陈佰义. 多黏菌素B与利福平对亚胺培南耐药鲍曼不动杆菌联合药物敏感性研究[J]. 中华检验医学杂志,2006,(4):370
[26] 戴春梅,郑兰香,陈辉. 129株鲍曼不动杆菌所致医院感染的耐药性分析[J]. 实用预防医学,2006,(1):62
[27] 刘欣,徐娟,洪纯,等. 丁香酚和大蒜素分别与亚胺培南联用对多耐药鲍曼不动杆菌的体外抑菌实验研究[J]. 抗感染药学,2017, 14(1):17
[28] Gao W,Gopala L,Bheemanaboina RRY,et al. Discovery of 2-aminothiazolyl berberine derivatives as effectively antibacterial agents toward clinically drug-resistant Gram-negative Acinetobacter baumannii[J]. Eur J Med Chem,2018,146:15
[29] 史鹏伟,高艳彬,卢志阳,等. 抗菌肽LL-37对鲍曼不动杆菌生物膜的抑制作用[J]. 南方医科大学学报,2014, 34(3):426
[1]文晓龙,权 伟,江荣才.神经外科重症监护室中脑外伤感染泛耐药鲍曼不动杆菌12例分析[J].天津医科大学学报,2015,21(03):255.
[2]余 倩,胡志东,李 静,等.3种方法评估肺炎克雷伯菌及鲍曼不动杆菌对替加环素的体外药敏结果分析[J].天津医科大学学报,2015,21(06):510.
YU Qian,HU Zhi-dong,LI Jing,et al.Effect of Tigecycline on Klebsiella pneumoniae and Acinetobacter baumanaii by susecptibility testing in vitro[J].Journal of Tianjin Medical University,2015,21(06):510.
[3]张 燕,何新飙.ICU患者感染鲍曼不动杆菌的危险因素及耐药性分析[J].天津医科大学学报,2016,22(04):318.
ZHANG Yan,HE Xin-biao.Analysis of risk factors and drug resistance of the patients fected with Acinetobater baumanii in intensive care unit[J].Journal of Tianjin Medical University,2016,22(06):318.
[4]翟慧群,班 博.鲍曼不动杆菌感染对气管插管患者预后的影响[J].天津医科大学学报,2016,22(04):335.
[5]孔海芳,胡志东.碳青霉烯耐药鲍曼不动杆菌的临床特征及克隆变迁[J].天津医科大学学报,2020,26(05):471.
KONG Hai-fang,HU Zhi-dong.Clinical characteristics and clonal dynamics of carbapenem-resistant Acinetobacter baumannii infections[J].Journal of Tianjin Medical University,2020,26(06):471.
[6]曹源,崔晓慧,梁歌宏,等.下呼吸道感染鲍曼不动杆菌毒力基因携带情况及与预后的相关性分析[J].天津医科大学学报,2023,29(04):427.
CAO Yuan,CUI Xiao-hui,LIANG Ge-hong,et al.Virulence gene carrying of Acinetobacter baumannii in lower respiratory tract infection and its correlation with prognosis[J].Journal of Tianjin Medical University,2023,29(06):427.